• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Adv . Heteromultivalent topology-matched nanostructures as potent and broad-spectrum influenza A virus inhibitors

tetano

Editor, Senior Moderator
Sci Adv


. 2021 Jan 1;7(1):eabd3803.
doi: 10.1126/sciadv.abd3803. Print 2021 Jan.
Heteromultivalent topology-matched nanostructures as potent and broad-spectrum influenza A virus inhibitors


Chuanxiong Nie[SUP] 1 2 [/SUP], Marlena Stadtm?ller[SUP] 2 [/SUP], Badri Parshad[SUP] 1 3 [/SUP], Matthias Wallert[SUP] 1 [/SUP], Vahid Ahmadi[SUP] 1 [/SUP], Yannic Kerkhoff[SUP] 1 [/SUP], Sumati Bhatia[SUP] 1 [/SUP], Stephan Block[SUP] 4 [/SUP], Chong Cheng[SUP] 5 [/SUP], Thorsten Wolff[SUP] 6 [/SUP], Rainer Haag[SUP] 4 [/SUP]



Affiliations
Free article

Abstract

Here, we report the topology-matched design of heteromultivalent nanostructures as potent and broad-spectrum virus entry inhibitors based on the host cell membrane. Initially, we investigate the virus binding dynamics to validate the better binding performance of the heteromultivalent moieties as compared to homomultivalent ones. The heteromultivalent binding moieties are transferred to nanostructures with a bowl-like shape matching the viral spherical surface. Unlike the conventional homomultivalent inhibitors, the heteromultivalent ones exhibit a half maximal inhibitory concentration of 32.4 ? 13.7 μg/ml due to the synergistic multivalent effects and the topology-matched shape. At a dose without causing cellular toxicity, >99.99% reduction of virus propagation has been achieved. Since multiple binding sites have also been identified on the S protein of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), we envision that the use of heteromultivalent nanostructures may also be applied to develop a potent inhibitor to prevent coronavirus infection.
 
Back
Top Bottom